- Home
- MRK vs JLS Comparison
MRK vs JLS Comparison
Compare MRK & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | JLS |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 94.1M |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MRK | JLS |
|---|---|---|
| Price | $143.59 | $16.25 |
| Analyst Decision | Buy | |
| Analyst Count | 28 | 0 |
| Target Price | ★ $154.62 | N/A |
| AVG Volume (30 Days) | ★ 5.2M | 19.9K |
| Earning Date | 10-29-2026 | 01-01-0001 |
| Dividend Yield | 2.34% | ★ 9.33% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.29 | N/A |
| Revenue Next Year | $4.59 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $82.01 | $16.01 |
| 52 Week High | $157.00 | $18.98 |
Technical Indicators
Market Signals| Indicator | MRK | JLS |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 39.39 |
| Support Level | $142.32 | N/A |
| Resistance Level | $153.19 | $16.59 |
| Average True Range (ATR) | 3.19 | 0.21 |
| MACD | -0.73 | 0.01 |
| Stochastic Oscillator | 18.84 | 45.78 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. The Fund's investment objective is to provide a high level of current income.